The construction of hybridomas producing monoclonal antibodies for new, more specific diagnostic kits for the detection of colon cancer and some air allergens.
To develop, manufacture, test and introduce to the market a completely new type of medical device for vacuum therapy.
We aim to develop antigen specific t cells against different muc1 glycoforms by means of differentiating stem cells in an artificial thymus towards dcs and t cells. These dcs will be transduced with ad-muc1 and given to t cells to generate antigen specific t cells that can be cloned.
Production and testing of biomedical shape memory alloys, development of suitable training methods and devices to induce the 2-way shape memory effect, and investigation of its long-term stability and testing of alloy biocompatibility.
Apart from in humans, iron deficiency is still a major problem in several segments of the livestock industry, with piglet anaemia as the most widespread. The main objective of this project is to develop a new hem-iron product obtained from pig blood waste in slaughterhouses.
The purpose of this project is the study, the interpretation and the utilisation of the effects of migration that an ultrasound field produces in inclusions of micro and nano bubbles, with therapeutic purpose in different medicine fields.
The evaluation of biological activity of processing by-products from more widely grown japanese quince and black currant cultivars.
A novel biomimetic bioreactor for biomaterial/tissue characterization/cultivation under precisely defined conditions mimicking those in intervertebral discs will be constructed. Bioreactor optimization will be performed in conjunction with development and assessment of novel biomedical biomaterials.
The scope of this project is to complete the r&d required for obtaining the market authorization of a new recombinant vaccine against canine leishmaniasis, which has been shown protective in experimental trials in dogs with better performance than that of gold-standards.